UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

TLR4 Polymorphisms and Risk of Skin Cancer

Completed

Conditions: Skin Cancer

First Posted Date: 2017-04-20

Last Posted Date: 2023-03-22

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 392

Registration Number: NCT03122366

Locations: 🇺🇸
The Kirklin Clinic, Birmingham, Alabama, United States

Pain Management in Head and Neck Surgery Patients

Phase 4

Withdrawn

Conditions: Pain Management

Interventions: Drug: Hydrocodone-Acetaminophen
Drug: Oxycodone
Drug: Acetaminophen
Drug: Gabapentin
Drug: Celecoxib

First Posted Date: 2017-04-20

Last Posted Date: 2021-06-22

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT03121963

Individualized Cognitive Training in HIV

Not Applicable

Completed

Conditions: Aging
Cognitive Decline
Attention Impaired
Cognitive Impairment
Cognitive Deficit in Attention
Processing, Visual Spatial
Cognitive Disorder in Remission
HIV-Associated Cognitive Motor Complex

Interventions: Other: No-Contact Control
Behavioral: Individualized Cognitive Training

First Posted Date: 2017-04-20

Last Posted Date: 2021-10-19

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 109

Registration Number: NCT03122288

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Tele-Exercise and Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Behavioral: TeleCAM
Behavioral: DirectCAM
Behavioral: rDirectCAM

First Posted Date: 2017-04-18

Last Posted Date: 2024-12-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 911

Registration Number: NCT03117881

Locations: 🇺🇸
Upstream Rehabilitation Inc., Winchester, Tennessee, United States
🇺🇸
Tanner Foundation, Birmingham, Alabama, United States
🇺🇸
Southeast Alabama Medical Center Rehabilitation Services, Dothan, Alabama, United States

and more 9 locations

Constraint-induced Movement Therapy to Improve Gait and Mobility of People With Chronic Stroke

Not Applicable

Completed

Conditions: Rehabilitation
Lower Extremity Paresis
Recovery of Function
Stroke

Interventions: Behavioral: Lower extremity Constraint-induced movement therapy(LE-CIMT)

First Posted Date: 2017-04-14

Last Posted Date: 2023-01-23

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 8

Registration Number: NCT03114046

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus

Phase 2

Withdrawn

Conditions: Refractory Epilepsy

Interventions: Drug: Ketamine Infusion (Group K)
Drug: Traditional Treatment (Group T)

First Posted Date: 2017-04-14

Last Posted Date: 2021-05-21

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT03115489

Locations: 🇺🇸
UAB Department of Anesthesiology and Perioperative Medicine, Birmingham, Alabama, United States

Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea

Phase 2

Terminated

Conditions: Sleep Apnea
Obstructive Sleep Apnea
Postoperative Complications

Interventions: Procedure: Control
Drug: Ketamine

First Posted Date: 2017-04-12

Last Posted Date: 2019-12-19

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 9

Registration Number: NCT03109418

Locations: 🇺🇸
UAB Department of Anesthesiology and Perioperative Medicine, Birmingham, Alabama, United States

Phase I Trial of PACE for Metastatic Prostate Cancer

Phase 1

Withdrawn

Conditions: Metastatic Prostate Cancer

Interventions: Drug: PACE with Cabazitaxel (15 mg/m2)
Drug: PACE with Cabazitaxel (20 mg/m2)

First Posted Date: 2017-04-12

Last Posted Date: 2020-10-19

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT03110588

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Bupivacaine With Epidural Volume Extension

Phase 3

Completed

Conditions: Spinal Anesthesia
Epidural; Anesthesia

Interventions: Drug: 10 mg Bupivacaine
Drug: 5 mg Bupivacaine

First Posted Date: 2017-04-12

Last Posted Date: 2018-12-19

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 45

Registration Number: NCT03110003

Locations: 🇺🇸
UAB Department of Anesthesiology and Perioperative Medicine, Birmingham, Alabama, United States

Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish

Phase 4

Completed

Conditions: Onychomycosis of Toenail

Interventions: Drug: Efinaconazole 10% Topical Application Solution [JUBLIA]
Other: Application of Nail Polish

First Posted Date: 2017-04-12

Last Posted Date: 2019-06-27

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 13

Registration Number: NCT03110029

Locations: 🇺🇸
The Kirklin Clinic, Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy